Camille Engel

Camille Engel

Auto-generated profile, based on publicly available information

Camille Engel

Université de Franche-Comté, Centre de Génétique Humaine, CHU Besançon, Besançon, France.

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2023 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
CECamille Engel
Camille Engel
SVStéphanie Valence
Stéphanie Valence
GDGeoffroy Delplancq
Geoffroy Delplancq
RMReza Maroofian
Reza Maroofian
AAAndrea Accogli
Andrea Accogli
JPJuliette Piard
Juliette Piard
BRAT1 biallelic variants are associated with rigidity and multifocal seizure syndrome, lethal neonatal (RMFSL), and neurodevelopmental disorder associating cerebellar atrophy with or without seizures syndrome (NEDCAS). To date, forty individuals have been reported in the literature. We collected clinical and molecular data from 57 additional cases allowing us to study a large cohort of 97 individuals and draw phenotype-genotype correlations. Fifty-nine individuals presented with BRAT1-related RMFSL phenotype. Most of them had no psychomotor acquisition (100%), epilepsy (100%), microcephaly (91%), limb rigidity (93%), and died prematurely (93%). Thirty-eight individuals presented a non-lethal phenotype of BRAT1-related NEDCAS phenotype. Seventy-six percent of the patients in this group were able to walk and 68% were able to say at least a few words. Most of them had cerebellar ataxia (82%), axial hypotonia (79%) and cerebellar atrophy (100%). Genotype-phenotype correlations in our cohort revealed that biallelic nonsense, frameshift or inframe deletion/insertion variants result in the severe BRAT1-related RMFSL phenotype (46/46; 100%). In contrast, genotypes with at least one missense were more likely associated with NEDCAS (28/34; 82%). The phenotype of patients carrying splice variants was variable: 41% presented with RMFSL (7/17) and 59% with NEDCAS (10/17).

25 June 2025 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
CECamille Engel
Camille Engel
MRMichaela Rendek
Michaela Rendek
JAJessica Assoumani
Jessica Assoumani
EAEmanuela Argilli
Emanuela Argilli
FAFrancesca Ariani
Francesca Ariani
JPJuliette Piard
Juliette Piard

16 April 2024 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PKPaul Kuentz
Paul Kuentz
CECamille Engel
Camille Engel
MLMathieu Laeng
Mathieu Laeng
MCMartin Chevarin
Martin Chevarin
YDYannis Duffourd
Yannis Duffourd
PVPierre Vabres
Pierre Vabres
Here we report 19 additional patients with PIK3R1 mosaic variants with clinical phenotyping, showing that the PIK3R1 phenotype is indistinguishable from the PIK3CA-related phenotypes, although the megalencephaly-capillary malformation phenotype is consistently absent in patients with PIK3R1 variants. We also report novel PIK3R1 variants. We consider that the meaning of PROS should shift from ‘PIK3CA-related overgrowth spectrum’ to ‘PI3-kinase-related overgrowth spectrum’.

2 April 2026 in European Journal of Human Genetics
Verified
Journal Article
Closed access
CECamille Engel
Camille Engel
MRMichaela Rendek
Michaela Rendek
JAJessica Assoumani
Jessica Assoumani
EAEmanuela Argilli
Emanuela Argilli
FAFrancesca Ariani
Francesca Ariani
JPJuliette Piard
Juliette Piard